Aromatase-Inhibitor Related Joint Pain
Aromatase-Inhibitor Related Joint Pain is a side effect experienced by some individuals undergoing treatment with aromatase inhibitors, which are drugs used primarily to treat hormone-positive breast cancer, particularly in postmenopausal women. The condition manifests as aches and pains in various joints such as the fingers, hands, ankles, feet, knees, wrists, elbows, and shoulders.
Health Outcomes
- Improved Joint Function
- Improved Joint Pain
- Improved Pain Severity
- Increased Adverse Reactions
- Minor Adverse Effects
- No Adverse Health Effects
- No Change in Immune System Response
- No Effect on Growth Parameters
- No Impact on Negative Mood States
- No Significant Change in Health Variables
- No Significant Difference in Primary Outcomes
- No Significant Increase in Adverse Effects
- Reduced Adverse Event
- Reduced Adverse Event from Radiotherapy or Chemotherapy
- Reduced Adverse Reaction
- Reduced Arthralgia
- Reduced Hand Pain
- Reduced Hot Flush Frequency
- Reduced Incidence of Adverse Reaction
- Reduced Joint Tenderness
- Reduced Knee Pain
- Reduced Pain Duration
- Reduced Side Effect
- Reduced Soreness
- Reduced Treatment Complications
- Relieved Joint Pain